In‐Jae Oh

4.8k total citations
211 papers, 2.6k citations indexed

About

In‐Jae Oh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, In‐Jae Oh has authored 211 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Pulmonary and Respiratory Medicine, 108 papers in Oncology and 32 papers in Molecular Biology. Recurrent topics in In‐Jae Oh's work include Lung Cancer Treatments and Mutations (87 papers), Lung Cancer Research Studies (53 papers) and Lung Cancer Diagnosis and Treatment (37 papers). In‐Jae Oh is often cited by papers focused on Lung Cancer Treatments and Mutations (87 papers), Lung Cancer Research Studies (53 papers) and Lung Cancer Diagnosis and Treatment (37 papers). In‐Jae Oh collaborates with scholars based in South Korea, United States and Spain. In‐Jae Oh's co-authors include Young‐Chul Kim, Yong Soo Kwon, Cheol‐Kyu Park, Sung Chul Lim, Kyu‐Sik Kim, Yoo Duk Choi, Hee‐Jung Ban, Yu‐Il Kim, Kyu Sik Kim and Yu Il Kim and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

In‐Jae Oh

194 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
In‐Jae Oh South Korea 27 1.5k 1.1k 568 329 304 211 2.6k
Giovanni Rossi Italy 26 1.0k 0.7× 790 0.7× 442 0.8× 303 0.9× 164 0.5× 114 2.3k
Theodoros Karantanos United States 25 831 0.6× 758 0.7× 1.0k 1.8× 450 1.4× 159 0.5× 78 2.7k
Tetsuya Oguri Japan 28 984 0.7× 1.2k 1.1× 1.0k 1.8× 376 1.1× 191 0.6× 172 2.7k
Kazunori Fujitaka Japan 24 1.1k 0.7× 565 0.5× 424 0.7× 178 0.5× 182 0.6× 150 1.9k
Timothy Craig Allen United States 26 1.1k 0.8× 434 0.4× 669 1.2× 369 1.1× 233 0.8× 90 2.5k
Dani S. Zander United States 34 1.0k 0.7× 680 0.6× 757 1.3× 247 0.8× 464 1.5× 90 2.9k
Xiangning Fu China 27 775 0.5× 593 0.6× 828 1.5× 569 1.7× 159 0.5× 132 2.3k
Daniela Terracciano Italy 37 1.2k 0.8× 451 0.4× 1.1k 1.9× 728 2.2× 200 0.7× 134 3.1k
Shin Yup Lee South Korea 23 654 0.4× 493 0.5× 790 1.4× 397 1.2× 174 0.6× 143 1.7k

Countries citing papers authored by In‐Jae Oh

Since Specialization
Citations

This map shows the geographic impact of In‐Jae Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Jae Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Jae Oh more than expected).

Fields of papers citing papers by In‐Jae Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In‐Jae Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Jae Oh. The network helps show where In‐Jae Oh may publish in the future.

Co-authorship network of co-authors of In‐Jae Oh

This figure shows the co-authorship network connecting the top 25 collaborators of In‐Jae Oh. A scholar is included among the top collaborators of In‐Jae Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In‐Jae Oh. In‐Jae Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shin, Hong‐Joon, Chul‐Kyu Park, Yong Soo Kwon, et al.. (2025). Better Chemotherapeutic Response of Small Cell Lung Cancer in Never Smokers than in Smokers. Tuberculosis & respiratory diseases. 88(2). 334–341.
2.
Choi, Yoo Duk, Sung‐Ja Ahn, Young‐Chul Kim, et al.. (2024). Blood Lymphocytes as a Prognostic Factor for Stage III Non-Small Cell Lung Cancer with Concurrent Chemoradiation. Chonnam Medical Journal. 60(1). 40–40. 1 indexed citations
3.
Bae, Suk‐Chul, In‐Jae Oh, Cheol‐Kyu Park, et al.. (2024). Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial. Clinical Cancer Research. 30(8). 1478–1487. 3 indexed citations
4.
Park, Cheol‐Kyu, Ji‐Young Lee, Hyun-Ju Cho, et al.. (2023). Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells. 12(9). 1246–1246. 5 indexed citations
5.
Kim, Tae-Ok, Hong‐Joon Shin, Yong-Soo Kwon, et al.. (2023). Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer. Scientific Reports. 13(1). 18126–18126. 3 indexed citations
6.
Wang, Qi, Chunyu Li, Tracy L. Leong, et al.. (2023). Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer—a retrospective cohort study. Translational Lung Cancer Research. 12(2). 312–321. 9 indexed citations
7.
Sunkara, Vijaya, Juhee Park, Jonathan Sabaté del Río, et al.. (2023). Exosome Precipitation by Ionic Strength Modulation: ExoPRISM. ACS Applied Materials & Interfaces. 15(49). 56807–56819. 10 indexed citations
8.
Oh, In‐Jae, Cheol‐Kyu Park, Kyoung‐Bok Min, et al.. (2023). Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study. Thoracic Cancer. 14(27). 2777–2784. 2 indexed citations
9.
Kweon, Sun‐Seog, et al.. (2023). Effective Timing of Introducing an Inpatient Smoking Cessation Program to Cancer Patients. Yonsei Medical Journal. 64(4). 251–251. 1 indexed citations
10.
11.
12.
Kang, Da Hyun, Cheol‐Kyu Park, Chaeuk Chung, et al.. (2020). Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors. Immune Network. 20(3). e27–e27. 52 indexed citations
13.
An, Byung Chull, et al.. (2018). GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines. PLoS ONE. 13(9). e0204170–e0204170. 59 indexed citations
14.
15.
Park, Cheol‐Kyu, In‐Jae Oh, Kyu-Sik Kim, et al.. (2017). Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial. Clinical Lung Cancer. 18(4). e289–e296. 18 indexed citations
16.
Park, Cheol‐Kyu, Hyun-Wook Kang, In‐Jae Oh, et al.. (2016). Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study. Journal of Korean Medical Science. 31(12). 1914–1914. 3 indexed citations
17.
Kim, Yu‐Il, Seong Hoon Yoon, Hee‐Jung Ban, et al.. (2014). Prevalence of Chronic Sputum and Associated Factors in Korean Adults. Journal of Korean Medical Science. 29(6). 825–825. 3 indexed citations
18.
Oh, In‐Jae, et al.. (2014). Nematicidal Activity of Verticillium saksenae A-1 against the Pine Wood Nematode Bursaphelenchus mucronatus. 19(2). 81–86. 1 indexed citations
19.
Young, Su, In‐Jae Oh, Kyu Sik Kim, et al.. (2011). Mortality and Prognostic Factors in Acute Respiratory Distress Syndrome due to Tuberculosis. The Korean Journal of Internal Medicine. 81(4). 458–463.
20.
Young, Su, Eun Young Kim, Yoon Hee Kim, et al.. (2011). Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level. European Respiratory Journal. 38(Suppl 55). p2803–p2803. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Rossi Breakdown of academic impact, for papers by Theodoros Karantanos Breakdown of academic impact, for papers by Tetsuya Oguri Breakdown of academic impact, for papers by Kazunori Fujitaka Breakdown of academic impact, for papers by Timothy Craig Allen Breakdown of academic impact, for papers by Dani S. Zander Breakdown of academic impact, for papers by Xiangning Fu Breakdown of academic impact, for papers by Daniela Terracciano Breakdown of academic impact, for papers by Shin Yup Lee
Rankless by CCL
2026